Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.

ABSTRACT:

Background

Frequent mutations of the COVID-19 virus, such as the Delta and Omicron variants, have prolonged the pandemic. Rich countries have approved the booster shots (3^rd doses) of vaccine, but this causes further delay of vaccination in developing countries. This raises the risk of further mutations, which may lower the efficacy of currently available vaccines. As herd immunity by universal vaccination is essential to end the pandemic, the COVID-19 Vaccine Global Access (COVAX) facility has been established to provide developing countries with subsidized vaccines. However, a critical issue is that the developing countries also need to effectively deploy vaccines to citizens. Although this argument suggests positive effects of good national governance on vaccination c

SUBMITTER: Aida T 

PROVIDER: S-EPMC8941364 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature